Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05813899
Status:
TERMINATED
Last Update Posted:
2023-07-17
First Post:
2023-04-11
Brief Title:
Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
Sponsor:
Mackay Memorial Hospital
Organization:
Mackay Memorial Hospital
Study Overview
Official Title:
Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
Status:
TERMINATED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The covid-19 epidemic was calming down and not many people were suffering from the post covid 19 syndrome
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate whether probiotics PS23 can improve the symptoms of patients with long COVID-19 also to evaluate the effects on blood cortisol and inflammation-related indicators in patients
Detailed Description:
It is expected that a total of 120 subjects will be recruited within 3 years after IRB approval divided into two groups of 60 subjects respectively consuming PS23 heat-treated bacteria or placebo and completing the 6-week period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None